These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8910002)

  • 1. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells.
    Magarian-Blander J; Hughey RP; Kinlough C; Poland PA; Finn OJ
    Glycoconj J; 1996 Oct; 13(5):749-56. PubMed ID: 8910002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.
    Poland PA; Kinlough CL; Rokaw MD; Magarian-Blander J; Finn OJ; Hughey RP
    Glycoconj J; 1997 Jan; 14(1):89-96. PubMed ID: 9076518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
    Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
    J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
    Brossart P; Heinrich KS; Stuhler G; Behnke L; Reichardt VL; Stevanovic S; Muhm A; Rammensee HG; Kanz L; Brugger W
    Blood; 1999 Jun; 93(12):4309-17. PubMed ID: 10361129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
    Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K
    Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and effective T-cell recognition of cells transfected with a truncated human mucin cDNA.
    Magarian-Blander J; Domenech N; Finn OJ
    Ann N Y Acad Sci; 1993 Aug; 690():231-43. PubMed ID: 7690213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-restricted presentation of a single repeat of MUC1 mucin.
    Orr MK; Burnside JS; Phillips CA; Philip R; Dombrowski KE; Wright SE
    Immunol Invest; 2007; 36(3):271-83. PubMed ID: 17558710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.
    Wright SE; Rewers-Felkins KA; Quinlin IS; Fogler WE; Phillips CA; Townsend M; Robinson W; Philip R
    Immunol Invest; 2008; 37(3):215-25. PubMed ID: 18389441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 peptide epitopes associated with five different H-2 class I molecules.
    Apostolopoulos V; Haurum JS; McKenzie IF
    Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
    Ninkovic T; Kinarsky L; Engelmann K; Pisarev V; Sherman S; Finn OJ; Hanisch FG
    Mol Immunol; 2009 Nov; 47(1):131-40. PubMed ID: 19007994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.
    Pietersz GA; Li W; Osinski C; Apostolopoulos V; McKenzie IF
    Vaccine; 2000 Apr; 18(19):2059-71. PubMed ID: 10706970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro.
    Chen J; Li HY; Wang D; Zhao JJ; Guo XZ
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1509-18. PubMed ID: 21950745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
    Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
    Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells.
    Hiltbold EM; Ciborowski P; Finn OJ
    Cancer Res; 1998 Nov; 58(22):5066-70. PubMed ID: 9823312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
    Roulois D; Vignard V; Gueugnon F; Labarrière N; Grégoire M; Fonteneau JF
    Eur Respir J; 2011 Nov; 38(5):1117-26. PubMed ID: 21540305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
    Stepensky D; Tzehoval E; Vadai E; Eisenbach L
    Clin Exp Immunol; 2006 Jan; 143(1):139-49. PubMed ID: 16367945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
    J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site.
    Wright SE; Kilinski L; Talib S; Lowe KE; Burnside JS; Wu JY; Dolby N; Dombrowski KE; Lebkowski JS; Philip R
    J Immunother; 2000 Jan; 23(1):2-10. PubMed ID: 10687132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
    Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
    Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin-1-related T cell infiltration in colorectal carcinoma.
    Mulder WM; Stukart MJ; de Windt E; Wagstaff J; Scheper RJ; Bloemena E
    Cancer Immunol Immunother; 1996 Jul; 42(6):351-6. PubMed ID: 8830738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.